| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −6.1× | −1.7× | |
| Price / Book | 2.8× | 2.0× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −7.0× | −1.5× | |
| EV / EBITDA | −4.5× | −1.2× | |
| Earnings yield | −16.5% | −14.3% | |
| Free cash flow yield | −14.2% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,301.07 | +4.90% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.41 | +2.21% | $625.15B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.04 | +1.90% | $509B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $416.70 | +2.41% | $374.03B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.21 | +3.19% | $365.66B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.70 | +1.66% | $281.5B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $167.85 | +2.38% | $260.32B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $685.06 | +0.84% | $253.3B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $435.30 | +2.44% | $235.34B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.36 | +1.50% | $192.64B | 22.3× | 37.5% | +29.9% |
